Public Company

Tenaya Therapeutics, Inc.


Tenaya is a biotechnology company committed to a bold mission: to discover, design, develop and deliver curative therapies that address the underlying drivers of heart disease. Their vision is to change the treatment paradigm for heart disease, and in doing so improve and extend the lives of millions of individuals and families fighting this debilitating disease. We are advancing a pipeline of disease-modifying therapies developed using our product platforms and core internal capabilities to target defined sub-populations of patients with rare or highly prevalent forms of heart disease. They are revolutionizing the treatment of heart disease through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine.


Founded 2016
Type Public
Location San Francisco, California, USA


TNYA $2.70 -3.75% $(0.11)

Latest News

Tenaya Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update Mar 08, 2023 GlobeNewswire Inc. TN-201 IND Cleared in January; Plan to Begin Phase 1b Dosing in MYBPC3-associated HCM PatientsĀ in Third Quarter 2023
Tenaya Therapeutics to Participate in Upcoming Investor Conferences Feb 07, 2023 GlobeNewswire Inc. SOUTH SAN FRANCISCO, Calif., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop...
Tenaya Therapeutics, Inc. (TNYA) Upgraded to Buy: Here's What You Should Know Jan 26, 2023 Zacks Investment Research Tenaya Therapeutics, Inc. (TNYA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2...
4 Penny Stocks To Buy In January According To Insiders Jan 20, 2023 PennyStocks Penny stocks to buy according to these insiders in January. The post 4 Penny Stocks To Buy In January According To Insiders appeared first on...
Tenaya Therapeutics, Clear Channel Outdoor And These 2 Penny Stocks Insiders Are Aggressively Buying Jan 20, 2023 Benzinga The Dow Jones closed lower for the third straight session on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around...